CN104189673A - Drug for treating brain tumors and preparation method thereof - Google Patents
Drug for treating brain tumors and preparation method thereof Download PDFInfo
- Publication number
- CN104189673A CN104189673A CN201410414869.0A CN201410414869A CN104189673A CN 104189673 A CN104189673 A CN 104189673A CN 201410414869 A CN201410414869 A CN 201410414869A CN 104189673 A CN104189673 A CN 104189673A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinensis
- medicine
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a drug for treating brain tumors and a preparation method thereof, and relates to a brain tumor treatment technology. The drug is prepared from the following medicines by weight: 30g of selfheal, 30g of raw oyster shells, 30g of chrysanthemum indicum, 30g of salvia chinensis, 30g of Chinese sage herb,15g of earthworms, 9g of geckoes, 39g of centipedes, 15g of radix paeoniae rubra, 30g of rhizoma sparganii, 39g of scorpion, 9g of peach kernels, 20g of uncaria laevigata, 10g of Sichuan lovage rhizome, 9g of radix angelicae, 15g of polygala tenuifolia, 20g of radix trichosanthis, 9g of fruits of Chinese magnoliavine, 15g of radix ophiopogonis, 9g of gallnuts, 12g of dried tangerine or orange peel, 30g of radix pseudostellariae, 9g of juncus roemerianus, 9g of herba epimedii, 9g of rhizoma curculiginis and 3g of musk. The preparation method for the drug comprises the following steps: I, processing according to a processing method of traditional Chinese medicines according to the characteristic of each medicine; and II, crushing, namely crushing the processed medicines into powder.
Description
Technical field: the present invention relates to treat cerebroma technology, especially treat medicine and the preparation method of cerebroma.
Background technology: cerebroma means the tumor that grows in intracranial, also claims intracranial tumor.Comprise the many primary tumors of brain essence and adjacent tissue thereof and metastatic carcinoma and sarcoma, thereby intracranial tumor 1.8%, intracranial tumor, taking glioma as at most, accounts for 30.4%, meningioma, pituitary tumor, schwannoma, craniopharyngioma, metastatic carcinoma, blood vessel cancer, gallbladder matter tumor etc., reduce successively.Can occur in any age, adult and child are different in predilection site and type.Child taking under tentorium of cerebellum as predilection site, common have a cerebellar astrocytoma, the medulloblastoma of cerebellum center line, the ependymoma of joint four ventricles of the brain, the craniopharyngioma of saddle etc.Adult taking on tentorium of cerebellum as predilection site, be often Interhemispheric frontal lobe glioma, volume top meningioma, pituitary adenoma and acoustic neuroma etc.
Modern medicine is still fuzzy to the primary disease cause of disease, may be relevant with factors such as brain embryonal tissue abnormal development, heredity, chemistry.
The clinical manifestation of primary disease, can be summarized as symptoms of intracranial hypertension and local symptom two classes.The caused symptom of intracranial hypertension has headache, vomiting, visual disorder.Other also can occur that dizziness, tinnitus, drowsiness, diplopia, mental symptom, epilepsy, stiffness of the neck, corneal reflex goes down etc.; Local symptom performance has with the difference of cerebral tissue damaged part different, and the symptom of initial stage performance has the meaning that helps location.As tumor is positioned at frontal lobe carrying out property intellectual retardation, personality change, epilepsy as seen: as frontal lobe rear portion precentral motor area pressurized, produce contralateral hemiplegia etc., tumor is positioned at occipital lobe, show as side homonymous hemianopsia, be positioned at cerebellum, can have walking unstable, ataxia etc.
Primary disease diagnosis Main Basis: intracranial tumor is owing to comprising various diseases perhaps, and therefore diagnosis must, in conjunction with General Symptoms and local symptom and sign, be carried out nervous system level diagnosis, then is aided with objective special examined, can make diagnosis.
1, examination of cerebrospinal fluid, finds that cerebral is high, and the high or person's (ependymoma, medulloblastoma, metastatic carcinoma, melanoma etc.) that finds oncocyte of protein content, has diagnostic significance;
2, X-ray skull plain film, can make localization diagnosis to some tumor;
3, EEG (electrocardiogram) examination reaches 80% to the positive rate of tumor-localizing on curtain.
4, ultrasound investigation reaches 30% to tumor-localizing positive rate on curtain, and positive rate of localization reaches more than 80%, and meningioma, metastatic tumor, glioblast positive rate reach 90%.
5, immunologic test, can make early diagnosis to cerebroma.As meningitic related antigen (MSA), check the specific antibody in patients serum by immunodiffusion with MSA, found that the positive rate 62% of meningiomatosis human serum.Although do not attain at present perfectly, but be a up-and-coming method of early diagnosis;
6, angiography can reach 90% left and right to Interhemispheric level diagnosis rate, and etiologic diagnosis can reach 50% left and right, is one of at present conventional diagnostic method, but will notes iodine allergy and old people to be cautious use of;
7, the conventional positive contrast agent of 60%conrzg of ventriculography, ventricular system is developed good, and positive rate reaches 90%;
8, by computerized x-ray tomography brain scanner, be the advanced method of diagnosis of intracranial pathological changes.
According to the needs of the various features of intracranial tumor, select above inspection method, in conjunction with medical history, symptom and sign, can diagnose.
Modern medicine is treated primary disease, according to different tumors, selects the integrated approach treatments such as Radiotherapy, chemotherapy, immunity and Chinese herbal medicine to be advisable.Early stage excision is striven in operation, to can not excision person can be at interior decompression or outer decompression operation, in radiotherapy split and two kinds of extracorporeal irradiations, chemicals adopts scheme for combining more.Initiatively observe with two methods of adopting with Chinese medicine, immunotherapy are on probation.Primary disease tcm clinical practice belongs to the categories such as " wind-phlegm ", " wind syndrome of head ", " paralysis ", " vomiting ", " dizzy ", " asthenia ".The cause of disease is mainly suffered from a deficiency of the kidney by spleen, phlegm resistance, and QI and blood pent-up, due to liver-wind stirring up internally etc.
Summary of the invention: the medicine and the preparation method that the object of this invention is to provide a kind for the treatment of cerebroma with good efficacy, it has made up the vacancy of China's treatment cerebroma to a certain extent, the object of the present invention is achieved like this, the present invention is by Spica Prunellae 30 g, Concha Ostreae 30 g, Flos Chrysanthemi Indici 30 g, Herba Salviae Chinensis 30 g, Herba Salviae Chinensis 30 g, Pheretima 15 g, Gekko Swinhonis 9 g, Scolopendra 39 g, Radix Polygoni Ciliinerve 15 g, Rhizoma Sparganii 30 g, Scorpio 39 g, Semen Persicae 9 g, Ramulus Uncariae macrophyllae 20 g, Rhizoma Chuanxiong 10 g, the Radix Angelicae Dahuricae 9 g, Radix Polygalae 15 g, Radix Trichosanthis 20 g, Fructus Schisandrae Chinensis 9 g, Radix Ophiopogonis 15 g, Galla Chinensis 9 g, Pericarpium Citri Reticulatae 12 g, Radix Pseudostellariae 30 g, Medulla Junci 9 g, Herba Epimedii 9 g, Rhizoma Curculiginis 9 g, Moschus 3 g make, its preparation method is: the first step, according to the characteristic of every sample medicine, is concocted respectively according to the concocting method of Chinese medicine, second step is pulverized, and the medicine cooking is ground into powdery.
Treatment method: patient takes medicine 3 every day, each 6-10; Within 30 minutes after meal, take medicine, boiled water is taken after mixing it with water.10 days is a course for the treatment of, serve on 3 courses for the treatment of, and the state of an illness can take a turn for the better.
Taboo: period in a medicine, taboo Fructus Capsici, Bulbus Allii; Old people can not eat egg, Ovum Anas domestica.
Therapeutic outcome, in decades to sick medication, the unwanted various virus of patient's whole body is all discharged, and in health, scarce thing is filled.Accept altogether 560 people for medical treatment, effective percentage 90%.
Detailed description of the invention: embodiment 1, the present invention is by Spica Prunellae 15-45g, Concha Ostreae 15-45g, Flos Chrysanthemi Indici 15-45g, Herba Salviae Chinensis 15-45g, Herba Salviae Chinensis 15-45g, Pheretima 5-25g, Gekko Swinhonis 3-15g, Scolopendra 24-54g, Radix Polygoni Ciliinerve 5-25g, Rhizoma Sparganii 15-45g, Scorpio 24-54g, Semen Persicae 3-15g, Ramulus Uncariae macrophyllae 5-35g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 3-15g, Radix Polygalae 5-25 g, Radix Trichosanthis 10-20 g, Fructus Schisandrae Chinensis 4-14 g, Radix Ophiopogonis 5-25 g, Galla Chinensis 4-14 g, Pericarpium Citri Reticulatae 6-18 g, Radix Pseudostellariae 10-50 g, Medulla Junci 4-14 g, Herba Epimedii 4-14 g, Rhizoma Curculiginis 4-14 g, Moschus 1-5 g makes, its preparation method is: the first step, according to the characteristic of every sample medicine, is concocted respectively according to the concocting method of Chinese medicine, second step is pulverized, and the medicine cooking is ground into powdery.
Embodiment 2, the present invention is by Spica Prunellae 20-40g, Concha Ostreae 20-40g, Flos Chrysanthemi Indici 20-40g, Herba Salviae Chinensis 20-40g, Herba Salviae Chinensis 20-40g, Pheretima 10-20g, Gekko Swinhonis 6-12g, Scolopendra 29-49g, Radix Polygoni Ciliinerve 10-20g, Rhizoma Sparganii 20-40g, Scorpio 29-49g, Semen Persicae 6-12g, Ramulus Uncariae macrophyllae 10-30g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 6-12g, Radix Polygalae 10-20 g, Radix Trichosanthis 15-25 g, Fructus Schisandrae Chinensis 7-11 g, Radix Ophiopogonis 10-20 g, Galla Chinensis 7-11 g, Pericarpium Citri Reticulatae 9-15 g, Radix Pseudostellariae 20-40 g, Medulla Junci 7-11 g, Herba Epimedii 7-11 g, Rhizoma Curculiginis 7-11 g, Moschus 1-5 g
Embodiment 3, the present invention is by Spica Prunellae 25-35g, Concha Ostreae 25-35g, Flos Chrysanthemi Indici 25-35g, Herba Salviae Chinensis 25-35g, Herba Salviae Chinensis 25-35g, Pheretima 10-20g, Gekko Swinhonis 6-12g, Scolopendra 34-44g, Radix Polygoni Ciliinerve 10-20g, Rhizoma Sparganii 25-35g, Scorpio 34-44g, Semen Persicae 6-12g, Ramulus Uncariae macrophyllae 15-25g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 6-12g, Radix Polygalae 10-20 g, Radix Trichosanthis 15-25 g, Fructus Schisandrae Chinensis 7-11 g, Radix Ophiopogonis 10-20 g, Galla Chinensis 7-11 g, Pericarpium Citri Reticulatae 9-15 g, Radix Pseudostellariae 20-40 g, Medulla Junci 7-11 g, Herba Epimedii 7-11 g, Rhizoma Curculiginis 7-11 g, Moschus 1-5 g makes.
Embodiment 4, the present invention is by Spica Prunellae 30 g, Concha Ostreae 30 g, Flos Chrysanthemi Indici 30 g, Herba Salviae Chinensis 30 g, Herba Salviae Chinensis 30 g, Pheretima 15 g, Gekko Swinhonis 9 g, Scolopendra 39 g, Radix Polygoni Ciliinerve 15 g, Rhizoma Sparganii 30 g, Scorpio 39 g, Semen Persicae 9 g, Ramulus Uncariae macrophyllae 20 g, Rhizoma Chuanxiong 10 g, the Radix Angelicae Dahuricae 9 g, Radix Polygalae 15 g, Radix Trichosanthis 20 g, Fructus Schisandrae Chinensis 9 g, Radix Ophiopogonis 15 g, Galla Chinensis 9 g, Pericarpium Citri Reticulatae 12 g, Radix Pseudostellariae 30 g, Medulla Junci 9 g, Herba Epimedii 9 g, Rhizoma Curculiginis 9 g, Moschus 3 g, make.
Claims (4)
1. the medicine for the treatment of cerebroma, it is characterized in that: it is by Spica Prunellae 15-45g, Concha Ostreae 15-45g, Flos Chrysanthemi Indici 15-45g, Herba Salviae Chinensis 15-45g, Herba Salviae Chinensis 15-45g, Pheretima 5-25g, Gekko Swinhonis 3-15g, Scolopendra 24-54g, Radix Polygoni Ciliinerve 5-25g, Rhizoma Sparganii 15-45g, Scorpio 24-54g, Semen Persicae 3-15g, Ramulus Uncariae macrophyllae 5-35g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 3-15g, Radix Polygalae 5-25 g, Radix Trichosanthis 10-20 g, Fructus Schisandrae Chinensis 4-14 g, Radix Ophiopogonis 5-25 g, Galla Chinensis 4-14 g, Pericarpium Citri Reticulatae 6-18 g, Radix Pseudostellariae 10-50 g, Medulla Junci 4-14 g, Herba Epimedii 4-14 g, Rhizoma Curculiginis 4-14 g, Moschus 1-5 g makes, its preparation method is: the first step, according to the characteristic of every sample medicine, is concocted respectively according to the concocting method of Chinese medicine, second step is pulverized, and the medicine cooking is ground into powdery.
2. the medicine for the treatment of cerebroma according to claim 1, it is characterized in that: it is by Spica Prunellae 20-40g, Concha Ostreae 20-40g, Flos Chrysanthemi Indici 20-40g, Herba Salviae Chinensis 20-40g, Herba Salviae Chinensis 20-40g, Pheretima 10-20g, Gekko Swinhonis 6-12g, Scolopendra 29-49g, Radix Polygoni Ciliinerve 10-20g, Rhizoma Sparganii 20-40g, Scorpio 29-49g, Semen Persicae 6-12g, Ramulus Uncariae macrophyllae 10-30g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 6-12g, Radix Polygalae 10-20 g, Radix Trichosanthis 15-25 g, Fructus Schisandrae Chinensis 7-11 g, Radix Ophiopogonis 10-20 g, Galla Chinensis 7-11 g, Pericarpium Citri Reticulatae 9-15 g, Radix Pseudostellariae 20-40 g, Medulla Junci 7-11 g, Herba Epimedii 7-11 g, Rhizoma Curculiginis 7-11 g, Moschus 1-5 g makes.
3. the medicine for the treatment of cerebroma according to claim 1, it is characterized in that: it is by Spica Prunellae 25-35g, Concha Ostreae 25-35g, Flos Chrysanthemi Indici 25-35g, Herba Salviae Chinensis 25-35g, Herba Salviae Chinensis 25-35g, Pheretima 10-20g, Gekko Swinhonis 6-12g, Scolopendra 34-44g, Radix Polygoni Ciliinerve 10-20g, Rhizoma Sparganii 25-35g, Scorpio 34-44g, Semen Persicae 6-12g, Ramulus Uncariae macrophyllae 15-25g, Rhizoma Chuanxiong 5-15g, Radix Angelicae Dahuricae 6-12g, Radix Polygalae 10-20 g, Radix Trichosanthis 15-25 g, Fructus Schisandrae Chinensis 7-11 g, Radix Ophiopogonis 10-20 g, Galla Chinensis 7-11 g, Pericarpium Citri Reticulatae 9-15 g, Radix Pseudostellariae 20-40 g, Medulla Junci 7-11 g, Herba Epimedii 7-11 g, Rhizoma Curculiginis 7-11 g, Moschus 1-5 g makes.
4. the medicine for the treatment of cerebroma according to claim 1, is characterized in that: it be by Spica Prunellae 30 g, Concha Ostreae 30 g, Flos Chrysanthemi Indici 30 g, Herba Salviae Chinensis 30 g, Herba Salviae Chinensis 30 g, Pheretima 15 g, Gekko Swinhonis 9 g, Scolopendra 39 g, Radix Polygoni Ciliinerve 15 g, Rhizoma Sparganii 30 g, Scorpio 39 g, Semen Persicae 9 g, Ramulus Uncariae macrophyllae 20 g, Rhizoma Chuanxiong 10 g, the Radix Angelicae Dahuricae 9 g, Radix Polygalae 15 g, Radix Trichosanthis 20 g, Fructus Schisandrae Chinensis 9 g, Radix Ophiopogonis 15 g, Galla Chinensis 9 g, Pericarpium Citri Reticulatae 12 g, Radix Pseudostellariae 30 g, Medulla Junci 9 g, Herba Epimedii 9 g, Rhizoma Curculiginis 9 g, Moschus 3 g make.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410414869.0A CN104189673A (en) | 2014-08-22 | 2014-08-22 | Drug for treating brain tumors and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410414869.0A CN104189673A (en) | 2014-08-22 | 2014-08-22 | Drug for treating brain tumors and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104189673A true CN104189673A (en) | 2014-12-10 |
Family
ID=52075144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410414869.0A Pending CN104189673A (en) | 2014-08-22 | 2014-08-22 | Drug for treating brain tumors and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104189673A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721753A (en) * | 2015-04-10 | 2015-06-24 | 山东三生新材料科技有限公司 | Medicine for treating liver-wind stirring type brain tumor and preparation method of medicine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1486740A (en) * | 2003-08-28 | 2004-04-07 | 肖厚杰 | Chinese medicine composition for treating cancer |
-
2014
- 2014-08-22 CN CN201410414869.0A patent/CN104189673A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1486740A (en) * | 2003-08-28 | 2004-04-07 | 肖厚杰 | Chinese medicine composition for treating cancer |
Non-Patent Citations (3)
Title |
---|
冯泳: "《临床常用方剂手册》", 31 January 2001, 贵州科技出版社 * |
李松林: "中医药治疗脑胶质瘤的现状与展望", 《浙江中医杂志》 * |
霍介格等: "周仲瑛治疗脑瘤经验", 《中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721753A (en) * | 2015-04-10 | 2015-06-24 | 山东三生新材料科技有限公司 | Medicine for treating liver-wind stirring type brain tumor and preparation method of medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
Yan et al. | Traditional Chinese medicine herbal preparations in restless legs syndrome (RLS) treatment: a review and probable first description of RLS in 1529 | |
CN102671137A (en) | Medicine composition for treating diabetic nephropathy and preparation method of medicine composition | |
CN103007206A (en) | Oral liquid for treating chronic atrophic gastritis | |
CN101380412A (en) | Formulation for treating apoplexy | |
CN1660395A (en) | Formula of treating apoplexy | |
CN1907459A (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
CN102614442A (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN104208303B (en) | A kind of Chinese medicine preparation for treating hyperlipemia and preparation method thereof | |
CN104623579A (en) | Traditional Chinese medicine composition for treating uremia | |
CN104189673A (en) | Drug for treating brain tumors and preparation method thereof | |
CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
CN103816391A (en) | Traditional Chinese medicinal wine for treating osteomyelitis and preparation method thereof | |
CN106236858A (en) | The Chinese medicine formula of a kind ofization silt the kidney invigorating | |
CN105106758A (en) | Traditional Chinese medicine composition for treating phlegm and blood stasis type dizziness | |
CN104758588A (en) | Traditional Chinese medicine composition for treating dizziness | |
CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
CN105853935B (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
CN108653551A (en) | Treat the drug and the preparation method and application thereof of the proliferation of mammary gland | |
CN104324135A (en) | Traditional Chinese medicine composition for treating ischemic stroke and preparation method and application of traditional Chinese medicine composition | |
CN103721188B (en) | A kind of injection care drug preventing cerebrovascular sclerosis and preparation method thereof | |
CN104013831B (en) | A kind of medicine for treating cerebral blood supply insufficiency | |
CN107233540A (en) | A kind of Chinese medicine composition for treating rheumatoid arthritis | |
CN105998254A (en) | Medicine for treating diabetes and preparation method thereof | |
CN105833016A (en) | Traditional Chinese medicine composition for treating ovarian cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |